FierceHealthcare names CivicaRx as one of it’s 2019 “Fierce 15” Companies

FierceHealthcare names CivicaRx as one of it's 2019 “Fierce 15” Companies

Civica Rx is honored to have been named by FierceHealthcare as one of the 2019 Fierce 15 companies, designating it as one of the most promising healthcare companies in the industry.

The Fierce 15 celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition.  This is FierceHealthcare’s first annual Fierce 15 selection.

Civica Rx was established in 2018 by three philanthropies and seven leading health systems that experience first-hand the impact of drug shortages, which have become all too common and affect all aspects of the health care delivery system. The highly-collaborative initiative will result in lower costs and more predictable supplies of many medicines, helping ensure that patients and their needs come first in the generic drug marketplace.

Most recently, Civica Rx announced that 12 health additional systems (include hyperlink to Jan 7 press release), representing approximately 250 hospitals across the United States, have joined the new not-for-profit generic drug company as founding members. When combined with hospitals represented by the initial governing members of Civica Rx, approximately 750 U.S. hospitals have joined the mission-driven venture so far, with many more health systems expressing interest.

"This year's Fierce15 winners show companies both large and small are finding new and innovative ways to tackle healthcare's most pressing challenges,” said Tina Reed, FierceHealthcare’s executive health and hospitals editor.

About FierceHealthcare

FierceHealthcare is the healthcare industry's daily monitor, an email newsletter and web resource providing the latest news, articles, and resources related to healthcare organizations and providers, Medicare/Medicaid/CMS, policies & regulations, healthcare reform and more. More than 120,000 top healthcare professionals rely on FierceHealthcare for an insider briefing on the day's top stories.

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top